Bochner Eye Institute First in Canada to Offer KXL® Accelerated Cross-linking Procedure for Keratoconus Patients

TORONTO, May 18, 2011 /CNW/ - The Bochner Eye Institute is the first centre in Canada to offer the KXL System for Accelerated Cross-linking - a non-invasive, incision‐less procedure for treating keratoconus.

"Surgeons at the Bochner Eye Institute are always at the forefront of new technology and are among the most experienced at corneal cross-linking in the world," said David Muller, PhD, CEO of Avedro.

Keratoconus is a degenerative disorder, which causes the cornea to thin and bulge from its natural state to a conical shape resulting in distortion of vision, and is a leading cause of corneal transplants.  The KXL System provides therapeutic treatment for keratoconus in just a few minutes, as opposed to the previous treatments that took over an hour to complete.

"The KXL procedure is a breakthrough in corneal cross-linking that has proven safe and effective in stopping the progression of keratoconus," says Raymond Stein, MD, FRCSC, Medical Director of Bochner Eye Institute.

Corneal cross-linking combines the application of riboflavin with ultraviolet‐A (UVA) light. Together, these increase corneal strength and stability by inducing new cross-links between or within collagen fibers. In multiple international clinical trials, cross-linking has been shown to halt the progression of keratoconus and to enhance the biomechanical stability of the cornea.

"Were happy to offer our keratoconic patients a safe, non-surgical alternative to corneal transplants that quickly and gently reshapes the cornea," says Albert Cheskes, MD, FRCSC, Medical Director of Bochner Eye Institute.

Key benefits of the KXL System include:

Speed: 3 minutes, 30 mW/cm"
Performance: Internal power calibration, increased depth of field, computer controlled
Predictability: Top hat homogeneous beam profile

About Avedro, Inc.
Avedro, a privately held ophthalmic device and drug company based in Waltham, MA, developed the KXL System for performing Accelerated Cross-linking. For more information on Avedro, visit

About The Bochner Eye Institute
The Bochner Eye Institute was established in 1929 and is a full-service ophthalmic surgical facility. Surgical procedures include cataract surgery, LASIK, PRK, PTK, corneal cross-linking, intracorneal rings, phakic implants, and therapeutic YAG and SLT laser treatments. A diagnostic centre provides testing with elevation and curvature topography, optical coherence topography, high-resolution fundus and anterior segment photography, specular microscopy, and biomechanical properties of the cornea. The surgeons at the Bochner Eye Institute all have academic appointments to the University of Toronto and have authored over 35 books.

SOURCE Bochner Eye Institute

For further information:

Kristin Mallon
Director of Marketing and Education
416-960-2020 ext 258

Profil de l'entreprise

Bochner Eye Institute

Renseignements sur cet organisme


Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .


Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.


Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.